STAD 2

Catalog No.: A37169
PKA-RII Disruptor
STAD 2 is a potent and selective disruptor of protein kinase A regulatory subunit type II (PKA-RII), exhibiting a dissociation constant (Kd) of 6.2 nM. It specifically interferes with the interactions between PKA and A-kinase anchoring proteins (AKAP) in an isoform-selective manner. Additionally, STAD 2 demonstrates antimalarial activity through a mechanism that is independent of PKA, making it a valuable tool for research into PKA-related signaling pathways and malaria therapeutics.
Grouped product items
Size Price Stock Qty
5mg
$435.00
In stock
10mg
$860.00
In stock
Bulk Size
Bulk Discount
Free Delivery on orders over $500
Research use only. We do not sell to patients.

Loading distributor info...

Adooq Products cited in reputable paper
Science VOLUME 380, ISSUE 6663 (2023)
Science VOLUME 369, ISSUE 6510 (2020)
Science VOLUME 356, ISSUE 6336 (2017)
Cell Vol. 185 Issue 23 p4428-4447.e28
Cell Vol 177, Issue 7, p1933-1947.e25
Cell Vol 156, Issue 5, p857-1114
Nature Volume 622 Issue 7982 (2023)
Nature volume 620, pages890-897 (2023)
Nature volume 610, pages540-546 (2022)
Nature volume 588, pages83-88 (2020)
Nature volume 574, pages268-272 (2019)
Nature volume 573, pages539-545 (2019)
Nature volume 567, pages118-122 (2019)
Nature volume 551, pages639-643 (2017)
Nature volume 551, pages247-250 (2017)
Nature volume 548, pages356-360 (2017)
Nature volume 545, pages187-192 (2017)
Biological Activity
DescriptionSTAD 2 is a potent and selective disruptor of protein kinase A regulatory subunit type II (PKA-RII), exhibiting a dissociation constant (Kd) of 6.2 nM. It specifically interferes with the interactions between PKA and A-kinase anchoring proteins (AKAP) in an isoform-selective manner. Additionally, STAD 2 demonstrates antimalarial activity through a mechanism that is independent of PKA, making it a valuable tool for research into PKA-related signaling pathways and malaria therapeutics.
Product Information
Catalog NumA37169
FormulaC102H182N24O22
Molecular Weight2096.68
CAS Number1542100-77-5
Sequence{PEG3}-Lys-Lys-Leu-Ala-Lys-Phe-Leu-Val-Ser-{Aaa}-Ala-Leu-Lys-{Aaa}-Ala-Leu-Lys (Covalent bridge:Aaa10-Aaa14)
Sequence shortening{PEG3}-KKLAKFLVS{Aaa}ALK{Aaa}ALK (Covalent bridge:Aaa10-Aaa14)
SMILESCC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@]1(C)CCCC=CCCC[C@](C)(NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)COCCOCCOCCN)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N1)C(=O)N[C@@H](CCCCN)C(N)=O |w:18.17,@@:108|
Useful Calculator

This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:

Mass (mg) = Concentration (mM) × Volume (mL) × Molecular Weight (g/mol)

  • Mass

    Concentration

    Volume

    Molecular Weight

Please check COA/MSDS for correct molecular weight.

Calculate the dilution required to prepare a stock solution.
This equation is commonly abbreviated as: C1V1 = C2V2

  • C1

    V1

    C2

    V2